Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- GFI -7.9%, ECOM -6.4%, TRUP -5.7%, OHI -4.7%, QUOT -4.1%, KRNT -3.9%, TECK -3.5%,NBIX -3.2%, OXY -2.7%, FUN -2.7%, CSOD -2.6%, SKT -2%, CYRN -1.9%, ICPT -1.9%,SHPG -1.4%, ALKS -1.3%, STNG -0.9%
Other news:
- TTPH -51.9% (announces efficacy and safety of once-daily intravenous (IV) eravacycline compared to ertapenem for the treatment of patients with complicated urinary tract infections (cUTI) did not achieve statistical non-inferiority of eravacycline to ertapenem)
- AVGR -27% (Form EFFECT (Notice of Effectiveness for an S-1 offering))
- NMM -11.2% (prices 18.4 mln common units at $1.90 per unit)
- PIRS -10.9% (prices 5.5 mln shares of common stock at $8.00 per share)
- AVDL -10.5% (announces its wholly-owned subsidiary, Avadel Finance Cayman Limited, intends to offer, $125 mln principal amount of exchangeable senior notes due 2023)
- RARX -9.8% (announces $50 mln proposed public offering of common stock)
- ZN -6.3% (after closing near highs -- up 70% on the day)
- NKTR -5.5% (after announcing massive global development & commercialization collaboration with Bristol-Myers Squibb (BMY) as agreement seems to have thrown cold water on full takeout hopes)
- TYHT -4.4% (after making 30% move higher on Tuesday)
- PDCO -2.9% (continued weakness)
Analyst comments:
- CAR -4.8% (downgraded to Sell from Neutral at Goldman)
- LYG -1.2% (downgraded to Neutral from Outperform at Davy)
- DVAX -1.2% (downgraded to Neutral from Overweight at JP Morgan)